Reports: Schnucks opens infusion services center in St. Louis
NEW YORK — Schnuck Markets is expanding its presence in specialty pharmacy services, according to published reports.
The St. Louis Post-Dispatch reported that Schnucks opened its first Schnucks Infusion Solutions location last month in St. Louis, where the supermarket chain is based.
The 6,500-sq.-ft. facility provides infusion services for serious, chronic conditions like autoimmune diseases, hemophilia, cancers and others, staffed by nurses, pharmacists and pharmacy technicians who prepare infusions and administer them in patients’ homes or its ambulatory infusion center.
Schnucks has been involved in specialty for a while. In May 2012, it opened a stand-alone pharmacy in the pavilion of St. John’s Hospital in Springfield, Ill., its first stand-alone specialty pharmacy in Illinois. The 2,000-sq.-ft. pharmacy specializes in conditions like HIV, hepatitis, autoimmune disorders, organ transplants and cancers and replaced the specialty pharmacy at a nearby store.
FDA approves generic injectable antibiotic
SILVER SPRING, Md. – The Food and Drug Administration has approved a generic injectable antibiotic drug made by Emcure Pharmaceuticals, according to the agency.
The FDA approved Emcure’s vancomycin hydrochloride injection in the 5-g-per-vial strength.
The drug is a generic version of Vancocin, made by ViroPharma.
FDA approves Mylan’s generic version of Detrol LA
SILVER SPRING, Md. — The Food and Drug Administration has approved a generic drug made by Mylan for treating overactive bladder, according to agency records.
The FDA approved Mylan’s tolterodine tartrate extended-release capsules in the 2-mg and 4-mg strengths.
The drug is a generic version of Pfizer’s Detrol LA. Detrol LA has annual sales of about $700 million, according to published reports.